Ignite Creation Date:
2024-05-06 @ 7:39 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02572453
Status:
TERMINATED
Last Update Posted:
2022-09-13
First Post:
2015-10-08
Brief Title:
Phase 2 Study of AT13387 Onalespib in ALK ALCL MCL and BCL-6 DLBCL
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Transformed Non-Hodgkin Lymphoma |
| Recurrent Anaplastic Large Cell Lymphoma |
| Recurrent Diffuse Large B-Cell Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Transformed Non-Hodgkin Lymphoma |
| Refractory Anaplastic Large Cell Lymphoma |
| Refractory Diffuse Large B-Cell Lymphoma |
| Refractory Mantle Cell Lymphoma |
Keywords: